Archives
-
Urolithin A and the Metabolic Logic of Fibrosis
2026-10-05
Urolithin A offers translational researchers a way to investigate mitochondrial quality control alongside the metabolic dependencies of fibrotic disease. This article distinguishes established findings from hypothesis, connects mitophagy biology with the SIRT4–GDH glutamine axis, and outlines a rigorous path from mechanistic observation to clinically relevant interpretation.
-
Nonivamide: TRPV1 Biology and Cancer Evidence
2026-10-05
Nonivamide is a capsaicin analog and TRPV1 agonist used in sensory-neurobiology and cancer research contexts. Evidence supports TRPV1-mediated neuroimmune effects, while the available oncology claims remain model-specific and are based here primarily on a vendor dossier rather than the supplied peer-reviewed study.
-
SETD7 Depletion Promotes Fat Browning in Obesity
2026-10-04
The 2026 Cell Death & Differentiation study identifies SETD7 as a negative regulator of inguinal white adipose tissue thermogenesis in obese mice. Its genetic and cellular evidence connects reduced SETD7 activity with an Adcy7–Sirt1–CREB1 signaling axis, increased energy expenditure, and improved metabolic phenotypes, while leaving important questions about human translation unresolved.
-
Cardiogreen and the Next Wave of Translational Phototherapy
2026-10-03
Cardiogreen (Indocyanine Green) sits at the intersection of vascular diagnostics and light-responsive therapy. This evidence-led analysis examines how its translational potential relates to macrophage biology, immunogenic cell death, and the limits of extrapolating photothermal findings to photodynamic applications.
-
M344: Histone Deacetylase Inhibitor Workflows
2026-10-01
M344 is a cell-permeable histone deacetylase inhibitor for connecting chromatin remodeling with proliferation, differentiation, radiation response, and viral-latency assays. This practical guide covers dose selection, formulation, time-resolved readouts, comparative controls, and troubleshooting across cancer and ex vivo models.
-
hly Deletion Rewires Listeria Biofilms and Sensitivity
2026-10-01
The reference study shows that deleting hly in Listeria monocytogenes leaves planktonic growth intact but disrupts biofilm biomass, architecture, motility, surface properties, regulatory-gene expression, and sensitivity to selected antibiotics. Its paired genetic, microscopic, phenotypic, and RT-qPCR design supports a model in which hly contributes to coordinated biofilm and virulence regulation rather than acting only as a toxin gene.
-
Ginsenoside Rg1: A Causal Neuroimmune Guide
2026-09-30
Ginsenoside Rg1 is a Panax-derived triterpene saponin for investigating gut–immune–brain communication after prolonged anesthesia. This guide translates recent Treg-dependent findings into practical assay decisions, chemical-handling controls, and scientifically cautious neuroprotection research strategies.
-
Mitoxantrone HCl: From DNA Damage to ERα
2026-09-30
Mitoxantrone HCl is best understood not only as a DNA topoisomerase II inhibitor, but also as a mechanistic probe for ERα allostery, receptor degradation, and therapy resistance. This translational perspective connects experimental design, product handling, and strategic interpretation across cancer and immune-cell research.
-
SU 5402: RTK Logic for Complex Cell Models
2026-09-29
SU 5402 is a multi-target receptor tyrosine kinase inhibitor for mechanistic studies of VEGFR, FGFR, and PDGFR signaling. This guide connects its pathway-level pharmacology with a validated human sensory-neuron model while emphasizing assay controls, interpretation, and translational limits.
-
HotStart 2X Green qPCR Master Mix for Cancer Research
2026-09-29
Use HotStart™ 2X Green qPCR Master Mix to convert inflammation-focused cancer findings into specific, auditable gene-expression assays. Its antibody-mediated hot-start chemistry, SYBR Green detection, and flexible workflow support target panels, RNA-seq validation, and nucleic acid quantification without treating qPCR results as a substitute for orthogonal protein or pathology data.
-
APEX-RNA-MS Maps RNA Modifications in Cell Structures
2026-09-28
Seo, Dhingani, and Kleiner introduce APEX-RNA-MS, a workflow that combines APEX2 proximity labeling with nucleoside LC-MS to quantify modified RNA near defined cellular proteins. Applied to stress granules, P-bodies, and DNA damage foci, the method links m6A, m5C, and tRNA-associated modifications to spatially organized RNA biology while using RNA sequencing and FISH for orthogonal validation.
-
Olive Oil Polyphenols and Cardiovascular Mechanisms
2026-09-28
Boumezough and colleagues compared standard and high-phenolic extra virgin olive oil extracts with hydroxytyrosol and tyrosol in cellular models of oxidative stress, inflammation, and cholesterol handling. Their findings link polyphenol content with differences in antioxidant responses, macrophage markers, and cholesterol efflux, while leaving important questions about dose, mechanism, and translation to human cardiovascular outcomes.
-
PEGylated PLGA Microspheres for Sustained Steroid Release
2026-09-27
The study optimized hydrocortisone-17-butyrate-loaded PLGA microspheres and examined whether surface PEGylation could reduce early drug desorption while extending release. The reported in vitro results support the formulation concept, but do not establish joint retention, therapeutic benefit, or safety in animals or patients.
-
Safe DNA Gel Stain for RNA and DNA Workflows
2026-09-26
Safe DNA Gel Stain supports routine DNA and RNA gel checks while offering blue-light imaging as an alternative to UV-dependent workflows. See how to use it for nucleic-acid quality control, what it can—and cannot—tell you about RNA-targeting experiments, and how to troubleshoot common visualization problems.
-
FITC Goat Anti-Mouse IgG (H+L) Antibody Guide
2026-09-25
This FITC-labeled secondary antibody supports fluorescent detection of mouse IgG primary antibodies in immunofluorescence and flow cytometry. Use it when the primary antibody is from mouse and FITC is compatible with the assay; it is not a substitute for a primary antibody or an appropriate choice when FITC signal overlap or photobleaching limits readout.